• Elisabeth Schorb on the MARTA phase 2 trial

  • Feb 29 2024
  • Length: 9 mins
  • Podcast

Elisabeth Schorb on the MARTA phase 2 trial

  • Summary

  • Doctor Elisabeth Schorb joins us to discuss the MARTA phase 2 trial, treating older, fit patients with primary diffuse large B-cell CNS lymphoma with high-dose chemotherapy and autologous stem-cell transplantation.

    Read the full article:
    https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(23)00371-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanhae

    Continue this conversation on social!
    Follow us today at...
    https://twitter.com/thelancet
    https://instagram.com/thelancetgroup
    https://facebook.com/thelancetmedicaljournal
    https://linkedIn.com/company/the-lancet
    https://youtube.com/thelancettv

    Show more Show less

What listeners say about Elisabeth Schorb on the MARTA phase 2 trial

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.